| dc.date.accessioned | 2020-09-30T14:11:50Z | |
| dc.date.available | 2020-09-30T14:11:50Z | |
| dc.date.issued | 2020-09-03 | |
| dc.identifier.uri | https://www.nccmt.ca/uploads/media/media/0001/02/1cb5049ee8ea6cc913b7571590a50005c9e64349.pdf | en_US |
| dc.identifier.uri | https://hdl.handle.net/20.500.12663/2286 | |
| dc.description.abstract | Understanding the implications of COVID-19 infection during pregnancy may help public health practitioners to support expectant parents, and may guide obstetric care for patients with COVID-19. This rapid review was produced to support public health decision makers’ response to the coronavirus disease 2019 (COVID-19) pandemic. This review seeks to identify, appraise, and summarize emerging research evidence to support evidence-informed decision making. This rapid review is based on the most recent research evidence available at the time of release. A previous version was completed on May 15, 2020. This updated version includes evidence available up to August 17, 2020. In this rapid evidence review, we answer the question: Is there an increased risk of adverse maternal or fetal outcomes in women infected with COVID-19 during pregnancy? | en_US |
| dc.language | English | en_US |
| dc.subject | COVID-19 | en_US |
| dc.subject | Coronavirus | en_US |
| dc.subject | Coronavirus Infections | en_US |
| dc.subject | Infectious Diseases | en_US |
| dc.subject | Pregnancy | en_US |
| dc.title | Rapid Review Update 1: Is there an increased risk of adverse maternal or fetal outcomes in women infected with COVID-19 during pregnancy? | en_US |
| eihealth.country | Others | en_US |
| eihealth.category | Clinical characterization and management | en_US |
| eihealth.category | Health systems and services | en_US |
| eihealth.type | Published Article | en_US |
| eihealth.maincategory | Save Lives / Salvar Vidas | en_US |
| dc.contributor.corporatename | National Collaborating Centre for Methods and Tools | en_US |
